Shailesh Kumar
Senior Research Scientist | Cell Culture & Microbial Biotechnology
Post Graduate
Years at VMRC
Publications
My current focus is on identification and the resistance detection in microorganisms such as bacteria and fungi that can cause disease. We have to play a key role in making sure antibiotics against resistance microorganisms and to minimize the emergence and spread of antimicrobial resistance. We help to improve human lives by providing identification and by suggesting treatment drugs for diseases.
In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams.
The Journal of Antibiotics 66, 495-497.
Chaudhary M, Kumar S, Payasi A. 2013.
Prevalence and Antimicrobial Sensitivity of Extended-Spectrum β-Lactamase Producing Gram-Negative Bacteria from Clinical Settings in India from 2010-2012.
International Journal of Medicine and Medical Sciences 46, 1212-1217.
Chaudhary M, Kumar S, Payasi A. 2013.
Role of CSE1034 in Escherichia coli Biofilm Destruction.
Journal of Microbial & Biochemical Technology 5(3), 054-058.
Chaudhary M, Kumar S, Payasi A. 2013.
A novel approach to prevent candidiasis associated with long term administration of cephalosporins.
Journal of Pharmacy Research 6, 298-303.
Chaudhary M, Naidu K, Kumar S. 2013.
Characterization of quinolone-resistant genes and control of qnrB transfer by Potentox in clinical isolates.
Journal of Pharmacy Research 7, 62-69.
Chaudhary M, Kumar S, Payasi A. 2013.
Comparative antibacterial activity of a novel semisynthetic antibiotic: etimicin sulphate and other aminoglycosides.
World Journal of Microbiology and Biotechnology 28(12), 3365-71.
Chaudhary M, Naidu K, Kumar S, Payasi A. 2012.
Catering ESBL resistance challenge through the strategic combination of Ceftriaxone, Sulbactam, and Ethylenediaminetetraacetic Acid.
International Journal of Drug Development and Research 4 (1), 72-81.
Sudaroli M, Kumar S, Krishnaraju V. 2012.
A Novel Approach to Combat Acquired Multiple Resistance in Escherichia coli by using EDTA as Efflux Pump Inhibitor.
Journal of Microbial & Biochemical Technology 4, 6.
Chaudhary M, Kumar S, Payasi A. 2012.
A comparative study of Sulbactomax versus Ceftriaxone and a beta-lactamase inhibitor and their effect on mutant prevention in ESBL producing organisms.
International Journal of Drug Development & Research Vol. 3 (3).
Payasi A, Kumar S, Chaudhary M. 2011.
Microbial efficacy of Pirotum, A Fixed Dose Combination of Cefpirome Sulbactam, In Comparison With Cefpirome alone.
World Journal of innovations in Medicine Vol 2 (1).
Shrivastava SM, Kumar S, Chaudhary M. 2010.
An Evaluation of Antimicrobial Efficacy of Acnano against some Acne Causing Microorganisms.
International Journal of Drug Development and Research Vol 2(2).
Naithani V, Kumar S, Shrivastava SM, Pathak N, Chaudhary M. 2010.
Time-kill Curve Studies of Acnano Against Staphylococcus Aureus & Staphylococcus epidermidis.
International Journal of Drug Development and Research Vol 2(2).
Naithani V, Kumar S, Shrivastava SM, Pathak N, Chaudhary M. 2010.
Evaluation of Vancoplus versus Ceftriaxone Against Cephalosporin Resistance MRSA Strain in experimental Meningitis model Cardiovascular and hematological disorders.
Cardiovascular & Hematological Disorders-Drug Targets 10(2), 138-42.
Soni A, Chaudhary M, Dwivedi VM, Kumar S, Shrivastava SM. 2010.
Ceftriaxone-sulbactam combination: Microbial analysis by variation of ratios and comparative disc diffusion.
Current Research in Bacteriology 2, 50-55.
Shrivastava SM, Kumar S, Chaudhary M. 2009.
Comparative Study of Efficacy of Fixed Dose Combination of Ceftriaxone Sulbactam and Ceftriaxone Tazobactam.
Journal of Pure and Applied Microbiology 3 (2), 719-723.
Shrivastava SM, Shukla SK, Kumar S, Chaudhary M. 2009.
Microbial Efficacy Analysis of Potentox, a Fixed Dose Combination of Cefepime Amikacin with Cefepime and Amikacin Alone in a Citrobacter Braaki, Mycobacterium smegmatis, Acinetobacter Baumanii, and Neisseria mucosa.
Biomedical & Pharmacology Journal 2 (1), 95-98.
Shrivastava SM, Shukla SK, Kumar S, Chaudhary M. 2009.
Comparative Evaluation of Fixed Dose Combination of Ofloxacin and Ornidazole Against Some Aerobic Bacteria.
Trends in Medical Research 4 (2), 30-34.
Shrivastava SM, Kumar S, Chaudhary M. 2009.
Time-kill curve studies of ampucare against Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae and Proteus vulgaris.
Research Journal of Medicinal Plants 3, 116-122.
Shrivastava SM, Kumar S, Chaudhary M. 2009.
- Barkatullah Vishwavidyalaya Bhopal, Ph.D. (Pursuing)
- Dr. B. R. A. University Agra, PG- 2006
- Lucknow University, Graduation - 2004
